Skip to content

Effects of Compatibility Temperature and Specific Gravity on Spinal Anesthesia with Ropivacaine for Cesarean Section

Effects of Compatibility Temperature and Specific Gravity on Spinal Anesthesia with Ropivacaine for Cesarean Section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122577
Enrollment
Unknown
Registered
2026-04-15
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parturients with singleton pregnancy undergoing elective cesarean section

Interventions

23? Isobaric Reconstitution:0.5% Ropivacaine 15mg 3ml intrathecal injection (23? room temperature, isobaric)
30? Isobaric Reconstitution:0.5% Ropivacaine 15mg 3ml intrathecal injection (30? constant temperature, isobaric)
23? Hyperbaric Reconstitution:0.5% Ropivacaine 15mg 3ml intrathecal injection (23? room temperature, hyperbaric)
30? Hyperbaric Reconstitution:0.5% Ropivacaine 15mg 3ml intrathecal injection (30? constant temperature, hyperbaric)

Sponsors

Obstetris & Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women with ASA grade II, singleton pregnancies and who underwent elective cesarean section at full term were included

Exclusion criteria

Exclusion criteria: 1. Combined with pregnancy-related diseases (diabetes, hypertension, preeclampsia/eclampsia, cardiovascular or cerebrovascular diseases, placenta previa or placental abruption); 2. Contraindications for nerve block anesthesia (allergy to anesthetics, abnormal coagulation function, anticoagulant therapy, severe hypovolemia or hemodynamic instability); 3. Previous mental disorders or other systemic diseases of vital organs; 4. Height less than 150cm or more than 170cm, body mass index (BMI) greater than 30kg/m^2.

Design outcomes

Primary

MeasureTime frame
Maximum dermatomal level of pinprick sensory block within 15 minutes after administration;

Secondary

MeasureTime frame
Success rate of subarachnoid block;Time to reach maximum sensory block;Duration of maximum sensory block;Time to onset of complete motor block;Time to recovery from complete motor block;Total dose of rescue medication;Maternal body temperature;Neonatal outcomes (Apgar scores at 1 and 5 minutes);Surgical duration;Blood loss volume;

Countries

China

Contacts

Public ContactYang Chen

Obstetris & Gynecology Hospital of Fudan University

annie.114@163.com+86 21 56319900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026